Design efficiency in dose finding studies
暂无分享,去创建一个
[1] J O'Quigley,et al. Two-sample continual reassessment method. , 1999, Journal of biopharmaceutical statistics.
[2] Ethan Reiner,et al. A stopping rule for the continual reassessment method , 1998 .
[3] J G Ibrahim,et al. Longitudinal design for phase I clinical trials using the continual reassessment method. , 2000, Controlled clinical trials.
[4] E. Eisenhauer,et al. Multinomial phase II cancer trials incorporating response and early progression. , 1999, Journal of biopharmaceutical statistics.
[5] Nancy Flournoy,et al. Random Walks for Quantile Estimation , 1994 .
[6] J O'Quigley,et al. Continual reassessment method: a likelihood approach. , 1996, Biometrics.
[7] John O'Quigley,et al. Non-parametric optimal design in dose finding studies. , 2002, Biostatistics.
[8] Thomas M Braun,et al. The bivariate continual reassessment method. extending the CRM to phase I trials of two competing outcomes. , 2002, Controlled clinical trials.
[9] S. Møller,et al. An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses. , 1995, Statistics in medicine.
[10] S Zacks,et al. Cancer phase I clinical trials: efficient dose escalation with overdose control. , 1998, Statistics in medicine.
[11] S. Gupta,et al. Statistical decision theory and related topics IV , 1988 .
[12] J. Whitehead,et al. Bayesian decision procedures with application to dose-finding studies , 1997 .
[13] J O'Quigley,et al. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. , 1990, Biometrics.
[14] P F Thall,et al. A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials. , 1998, Biometrics.
[15] D. Faries,et al. Practical modifications of the continual reassessment method for phase I cancer clinical trials. , 1994, Journal of biopharmaceutical statistics.
[16] Jeffrey R. Eisele,et al. A Curve‐Free Method for Phase I Clinical Trials , 2000, Biometrics.
[17] T A Gooley,et al. Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation. , 1994, Controlled clinical trials.
[18] S. Piantadosi,et al. Improved designs for dose escalation studies using pharmacokinetic measurements. , 1996, Statistics in medicine.
[19] S. Goodman,et al. Some practical improvements in the continual reassessment method for phase I studies. , 1995, Statistics in medicine.
[20] B E Storer,et al. Design and analysis of phase I clinical trials. , 1989, Biometrics.